%0 Journal Article
%T Phenotypic Characterization and Prevalence of Carbapenemase-Producing <i>Acinetobacter baumanii</i> Isolates in Four Health Facilities in Cameroon
%A C¨¦cile Ingrid Djuikoue
%A Benhamed Nadjia
%A Paule Dana Djouela Djoulako
%A Celianthe Guegang
%A Cedric Seugnou Nana
%A H¨¦l¨¨ne Val¨¦rie Same Njanjo
%A Yemina Grace Kombeu
%A Christiane Kiyang Possi
%A Rodrigue Kamga Wouambo
%A Gandhi Ndieffouo Fosso
%A Merim¨¦ Joel Tchinda Talokou
%A Bianca Tchounga Chimi
%A Olivier Pomte
%A Agbor Michael
%A Benjamin D. Thumamo Pokam
%A Nicolas Antoine-Moussiaux
%J Open Journal of Medical Microbiology
%P 234-249
%@ 2165-3380
%D 2023
%I Scientific Research Publishing
%R 10.4236/ojmm.2023.133019
%X Background and Objective: Nowadays, the clinical
utility of carbapenems is threatened by the emergence of resistant bacteria, favored
by its increasing use. According to the WHO, Acinetobacter baumannii: nosocomial infection agent, tops the list of
priority antibiotic-resistant pathogens, considered to be the riskiest for humans.
This study sought to determine the prevalence of carbapenemase-producing Acinetobacter baumannii strains in four health
facilities in the Center and Littoral regions of Cameroon and the associated risk
factors. Materials and Method: An analytical cross-sectional study was conducted
over a six-month period from January to June 2022. All suspicious A. baumanii isolates obtained from pathological samples at the bacteriology
laboratory of the different health facilities were systematically collected and
re-identified. Re-identification and antimicrobial susceptibility Testing (AST) were performed using the VITEK 2 System and the Kirby-Bauer
method according to the guidelines of the Clinical and Laboratory Standards Institute
(CLSI). Detection and phenotypic characterization of carbapenemases was performed
according to adequate standard procedures. Results: A total of 168/226 clinical
isolates of Acinetobacter baumannii were
confirmed after re-identification, among which 52.69% derived from male patients,
55.09% from participants aged between 10 - 39 years old, and 46.71% from pus samples. A very high resistance rates to
all families of antibiotics was noted, except to colistin (10.2%). 40.12% of these
isolates produced carbapenemase, represented by 62.69% of class B and 37.31% of
class A. Carbapenemase production was observed only at HMR1,